Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Cirrhosis ascites treatment medicine

A cirrhotic ascites and drug technology, applied in the field of medicine, can solve the problems of water and electrolyte disorders, long-term use, slow curative effect of traditional Chinese medicine, etc., and achieve the effect of relieving pain, improving liver function, and quick results

Inactive Publication Date: 2017-06-16
HENAN SHUIJINGTOU CULTURAL MEDIA CO LTD
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Western medicine eliminates ascites quickly, focusing on improving liver function, using diuretics to increase the excretion of water and sodium, and promoting the resolution of ascites, but it is easy to cause water and electrolyte disorders
The curative effect of traditional Chinese medicine is slow, and it needs to be used for a long time

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Cirrhosis ascites treatment medicine
  • Cirrhosis ascites treatment medicine
  • Cirrhosis ascites treatment medicine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0016] In an embodiment of the present invention, a medicine for treating liver cirrhosis ascites is composed of the following raw materials in parts by weight: 7 parts of rutin, 1 part of benzbromarone, 11 parts of glycerin, and 3 parts of naringin.

[0017] Mix and grind benzbromarone and glycerol, pass through a 120-mesh sieve, add deionized water 3.7 times the mass of the two, then raise the temperature to 81°C, and stir at this temperature for 36 minutes to prepare mixture A. Put naringin and rutin into the mixture A, then ultrasonically treat at 56°C for 28 minutes with an ultrasonic power of 1000W, then stir at 61°C until dry, and granulate to obtain the drug.

Embodiment 2

[0019] In an embodiment of the present invention, a medicine for treating liver cirrhosis ascites is composed of the following raw materials in parts by weight: 15 parts of rutin, 5 parts of benzbromarone, 19 parts of glycerin, and 7 parts of naringin.

[0020] Mix and grind benzbromarone and glycerol, pass through a 120-mesh sieve, add deionized water 3.7 times the mass of the two, then raise the temperature to 83°C, and stir at this temperature for 39 minutes to prepare mixture A. Put naringin and rutin into the mixture A, then ultrasonically treat at 56°C for 28 minutes with an ultrasonic power of 1000W, then stir at 61°C until dry, and granulate to obtain the drug.

Embodiment 3

[0022] In an embodiment of the present invention, a medicine for treating liver cirrhosis ascites is composed of the following raw materials in parts by weight: 9 parts of rutin, 2 parts of benzbromarone, 13 parts of glycerin, and 4 parts of naringin.

[0023] Mix and grind benzbromarone and glycerol, pass through a 120-mesh sieve, add deionized water 3.7 times the mass of the two, then raise the temperature to 82°C, and stir at this temperature for 37 minutes to prepare mixture A. Put naringin and rutin into the mixture A, then ultrasonically treat at 56°C for 28 minutes with an ultrasonic power of 1000W, then stir at 61°C until dry, and granulate to obtain the drug.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a cirrhosis ascites treatment medicine. The medicine comprises, by weight, 7-15 parts of rutin, 1-5 parts of benzbromarone, 11-19 parts of glycerol and 3-7 parts of naringin. The medicine is prepared through the following steps: mixing and grinding the benzbromarone and the glycerol, sieving the obtained mixture by a 120 mesh sieve, adding deionized water with the mass 3.7 times the total mass of the benzbromarone and the glycerol, heating the obtained solution to 81-83 DEG C, and stirring the solution at 81-83 DEG C for 36-39 min to prepare a mixture A; and adding naringin and rutin to the mixture A, carrying out ultrasonic treatment at 56 DEG C for 28 min, stirring the obtained mixture at 61 DEG C until the mixture is dry, and granulating the dry mixture. The total effective treatment rate of cirrhosis ascites reaches 98% or above, and the medicine improves the liver functions of patients, corrects hypoproteinemia, rapidly eliminates ascites, and reduces complications. The cirrhosis ascites treatment medicine has the advantages of simple and easily available raw materials, simple preparation technology, low production cost, good curative effect, fast effect, no toxic or side effects, and suitableness for large-scale production and promotion.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to a medicine for treating liver cirrhosis ascites. Background technique [0002] Liver cirrhosis is a common clinical chronic progressive liver disease, which is diffuse liver damage caused by long-term or repeated effects of one or more causes. In my country, most of them are post-hepatitis cirrhosis, and a small part are alcoholic cirrhosis and schistosome cirrhosis. Histopathologically, extensive liver cell necrosis, nodular regeneration of residual liver cells, connective tissue hyperplasia, and fibrous septum formation lead to structural destruction of hepatic lobules and formation of pseudolobules. The liver gradually deforms and hardens and develops into cirrhosis. In the early stage, there are no obvious symptoms due to the strong compensatory function of the liver. In the later stage, liver function damage and portal hypertension are the main manifestations, and multiple...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/7048A61K31/343A61K31/047A61P1/16
CPCA61K31/7048A61K31/047A61K31/343
Inventor 不公告发明人
Owner HENAN SHUIJINGTOU CULTURAL MEDIA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com